Document is current
Any future updates will be listed below
-
Authors
Toda, Mitsutoshi https://orcid.org/0009-0000-5709-5598
Iekushi, Kazuma
Takahashi, Yuri
Kohsaka, Shun
-
Funding
Funding for this research was provided by:
Novartis Pharma K.K.
- License Information
-
More Information
Article History
Received: 15 May 2025
Accepted: 14 July 2025
First Online: 31 July 2025
Declarations
:
: This study was sponsored by Novartis Pharma K.K. Mitsutoshi Toda, Yuri Takahashi, Kazuma Iekushi are employees of Novartis Pharma K.K. Shun Kohsaka has received research funding from the Japan Society for the Promotion of Science, and has received consulting fees from Pfizer, outside of the submitted work. Data acquisition, statistical analysis, and drafting of the manuscript were performed by Social Survey Research Information Co., Ltd., funded by Novartis Pharma K.K.
: This study was approved by Kitamachi Clinic Ethical Review Committee of the Medical Corporation Tokeikai. The approval number was BGQ09833. The approval date was January 17, 2024. The study complied with the Declaration of Helsinki and the Ethical Guidelines for Medical and Health Research Involving Human Subjects (Ministry of Health, Labour and Welfare of Japan).
